GOMEKLI is the first and only medicine approved for both adults and children with NF1-PN –– Approval based on positive data ...

Gilead Sciences, Inc. ( NASDAQ: GILD) Q4 2024 Earnings Conference Call February 11, 2025 4:30 PM ET Jacquie Ross - SVP, Treasury & IR Daniel O'Day - Chairman, CEO Johanna Mercier - Chief Commercial ...

USD/JPY traders eye Japan’s machine tool orders and US CPI data for market direction. Will softer inflation revive Fed rate ...

EUR/USD traders found the buy button and bolstered the pair back above the 1.0350 level on Tuesday. Fiber broke out of a three-day down streak. Still, momentum remains limited, and the pair continues ...

The cryptocurrency market has continued to show resilience in the wake of trade tensions. Most majors have recorded some ...

Bio-Thera had entered into an exclusive licensing agreement with STADA Arzneimittel AG to commercialize BAT2506 in the European Union (UK), the United Kingdom (UK), Switzerland, and selected other ...

Octavian Therapeutics ("Octavian" or "the Company"), a leading clinical-stage innovator in neuropathic pain treatment, today announces a transformative rebrand, the appointment of a new Non-Executive ...

Biogen Inc. (NASDAQ:BIIB) shares tumbled to a 52-week low of $139.7, reflecting a stark downturn in the biotechnology firm's market performance. With a market capitalization of $20.38 billion and a ...

The Conference Forum has announced the 9th annual Patients as Partners® Europe event, scheduled for May 20-21, 2025, at the Royal National Hotel ...

The EMA anticipates that the ability to access scientific advice will foster innovation among medical device manufacturers.

1 Christoffersen M et al. Transthyretin Tetramer Destabilization and Increased Mortality in the General Population. JAMA ...